000 | 01026 a2200289 4500 | ||
---|---|---|---|
005 | 20250516042150.0 | ||
264 | 0 | _c20120322 | |
008 | 201203s 0 0 eng d | ||
022 | _a1029-2403 | ||
024 | 7 |
_a10.3109/10428194.2011.580027 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aJoerger, Markus | |
245 | 0 | 0 |
_aHigh-dose methotrexate in patients with primary central nervous system lymphoma: does drug exposure really matter? _h[electronic resource] |
260 |
_bLeukemia & lymphoma _cOct 2011 |
||
300 |
_a1825-7 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Comment | ||
650 | 0 | 4 |
_aCentral Nervous System Neoplasms _xpathology |
650 | 0 | 4 | _aFemale |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 | _aMale |
650 | 0 | 4 |
_aMethotrexate _xpharmacokinetics |
700 | 1 | _aHuitema, A D R | |
700 | 1 | _aIllerhaus, G | |
700 | 1 | _aFerreri, A J M | |
773 | 0 |
_tLeukemia & lymphoma _gvol. 52 _gno. 10 _gp. 1825-7 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.3109/10428194.2011.580027 _zAvailable from publisher's website |
999 |
_c20914148 _d20914148 |